Spotlight: Longevity in Context
Psychiatric disorders aren't just mental health conditions. They are a biological accelerator of brain aging.
But did you know that in later life, women account for the majority of cases in several neuropsychiatric and neurodegenerative disorders? They also tend to experience faster cognitive decline after diagnosis, and for many, the earliest signs of brain aging begin quietly in midlife. Yet the question remains: why are women more affected?
A major, and often overlooked, factor is menopause.
During this transition, estrogen and other ovarian hormones drop sharply. Estrogen isn't just a reproductive hormone; it plays a crucial role in the brain, supporting metabolism, synaptic function, and anti-inflammatory signaling. When it vanishes, so does a key layer of protection.
Research shows that even in cognitively normal women, brain scans during perimenopause reveal early signs of degeneration: reduced glucose metabolism, greater amyloid buildup, and volume loss in regions vulnerable to Alzheimer’s. In multiple sclerosis, menopause marks a turning point toward faster disability progression. In vascular dementia, increased cardiovascular risk post-menopause contributes to cognitive decline.
But menopause doesn't just raise the risk for neurodegenerative conditions; it also increases susceptibility to neuropsychiatric disorders.
Women are already more likely to experience depression and anxiety, but the risk spikes during and after menopause. In fact, new-onset major depression is common in women with no previous psychiatric history. The mechanisms are complex, involving hormone-driven shifts in serotonin, GABA, and HPA axis function, but the outcome is clear: mood disorders are more likely, more persistent, and more biologically damaging during this window.
Even cognitive symptoms, like memory lapses, brain fog, and executive dysfunction, often appear in midlife and may be dismissed as “normal aging.” For some, they are temporary. For others, especially those with early menopause or a history of depression, they may signal the earliest stages of dementia.
Despite all this, menopause remains largely absent from neuroscience research. Most clinical trials don’t track hormone status. Many lab models still default to males. And interventions for brain aging rarely consider sex-specific biology.
If you’re a woman in your 40s or 50s, this is the decade to invest in your cognitive health. Track symptoms. Prioritize cardiovascular and mental health. Don’t dismiss memory changes because early attention matters.
At the LSF, we're stepping up to not only empower women to have more control over their health, but we're intentionally working to fix the funding gaps in research. From identifying biomarkers to developing hormone-responsive prevention strategies, we’re working toward a future where women’s health is no longer left behind. Reach out to us to see how a contribution can drive significant impact.
Psychiatric disorders aren't just mental health conditions. They are a biological accelerator of brain aging.
But did you know that in later life, women account for the majority of cases in several neuropsychiatric and neurodegenerative disorders? They also tend to experience faster cognitive decline after diagnosis, and for many, the earliest signs of brain aging begin quietly in midlife. Yet the question remains: why are women more affected?
A major, and often overlooked, factor is menopause.
During this transition, estrogen and other ovarian hormones drop sharply. Estrogen isn't just a reproductive hormone; it plays a crucial role in the brain, supporting metabolism, synaptic function, and anti-inflammatory signaling. When it vanishes, so does a key layer of protection.
Research shows that even in cognitively normal women, brain scans during perimenopause reveal early signs of degeneration: reduced glucose metabolism, greater amyloid buildup, and volume loss in regions vulnerable to Alzheimer’s. In multiple sclerosis, menopause marks a turning point toward faster disability progression. In vascular dementia, increased cardiovascular risk post-menopause contributes to cognitive decline.
But menopause doesn't just raise the risk for neurodegenerative conditions; it also increases susceptibility to neuropsychiatric disorders.
Women are already more likely to experience depression and anxiety, but the risk spikes during and after menopause. In fact, new-onset major depression is common in women with no previous psychiatric history. The mechanisms are complex, involving hormone-driven shifts in serotonin, GABA, and HPA axis function, but the outcome is clear: mood disorders are more likely, more persistent, and more biologically damaging during this window.
Even cognitive symptoms, like memory lapses, brain fog, and executive dysfunction, often appear in midlife and may be dismissed as “normal aging.” For some, they are temporary. For others, especially those with early menopause or a history of depression, they may signal the earliest stages of dementia.
Despite all this, menopause remains largely absent from neuroscience research. Most clinical trials don’t track hormone status. Many lab models still default to males. And interventions for brain aging rarely consider sex-specific biology.
If you’re a woman in your 40s or 50s, this is the decade to invest in your cognitive health. Track symptoms. Prioritize cardiovascular and mental health. Don’t dismiss memory changes because early attention matters.
At the LSF, we're stepping up to not only empower women to have more control over their health, but we're intentionally working to fix the funding gaps in research. From identifying biomarkers to developing hormone-responsive prevention strategies, we’re working toward a future where women’s health is no longer left behind. Reach out to us to see how a contribution can drive significant impact.